Bottom line
VHT vs IYH: the short answer
VHT (Vanguard Health Care Index Fund) and IYH (iShares U.S. Healthcare ETF) have nearly the same top holdings — their top 25 positions are about 92% the same by weight.
But VHT is far broader, holding 407 positions to 103 for IYH, so beyond the top names it adds exposure IYH doesn't have.
VHT is cheaper at 0.09% vs 0.37% — a difference of $28 a year per $10,000 invested.
Over five years, VHT returned +7.2% a year vs +7.0% for IYH (reporting dates differ).
Updated Nov 19, 2026
VHT vs IYH side by side
| VHT | IYH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Vanguard | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.09% | 0.37% |
| Annual cost per $10k | $9 | $37 |
| 10-yr cost on $10k (prospectus) | $115 | $468 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +2.7% | +13.1% |
| 5-yr return (annualized) | +7.2% | +7.0% |
| 10-yr return (annualized) | +8.8% | +9.4% |
| Best quarter | +16.5% | +15.3% |
| Worst quarter | −13.1% | −12.7% |
| Net assets (fund) | $19.0B | $3.6B |
| Number of holdings | 407 | 103 |
| Portfolio turnover | 4% | 3% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VHT | IYH | Difference |
|---|---|---|---|
| 2024 | +2.7% | +3.1% | −0.4% |
| 2023 | +2.5% | +2.1% | +0.4% |
| 2022 | −5.5% | −4.4% | −1.1% |
| 2021 | +20.5% | +23.4% | −2.9% |
| 2020 | +18.2% | +15.5% | +2.7% |
| 2019 | +22.0% | +20.8% | +1.2% |
| 2018 | +5.6% | +5.9% | −0.3% |
| 2017 | +23.3% | +22.3% | +1.0% |
| 2016 | −3.3% | −2.8% | −0.5% |
| 2015 | +7.2% | +6.1% | +1.1% |
Source: Fund prospectus bar charts
Holdings overlap
22 of VHT's top 25 holdings also appear in IYH's top 25.
| Holding | VHT | IYH |
|---|---|---|
| Eli Lilly & Co | 14.04% | 15.11% |
| Johnson & Johnson | 8.47% | 10.17% |
| AbbVie Inc | 6.09% | 7.32% |
| UnitedHealth Group Inc | 5.45% | 6.16% |
| Merck & Co Inc | 4.66% | 5.31% |
| Thermo Fisher Scientific Inc | 2.93% | 3.52% |
| Amgen Inc | 2.87% | 3.42% |
| Gilead Sciences Inc | 2.64% | 2.66% |
| Intuitive Surgical Inc | 2.38% | 2.05% |
| Pfizer Inc | 2.35% | 2.35% |
| Abbott Laboratories | 2.35% | 3.02% |
| Bristol-Myers Squibb Co | 1.84% | 2.20% |
| Danaher Corp | 1.84% | 2.03% |
| Vertex Pharmaceuticals Inc | 1.80% | 2.00% |
| Stryker Corp | 1.66% | 1.86% |
Source: SEC Form N-PORT
VHT top 10
- Eli Lilly & Co — 14.04%
- Johnson & Johnson — 8.47%
- AbbVie Inc — 6.09%
- UnitedHealth Group Inc — 5.45%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Intuitive Surgical Inc — 2.38%
- Pfizer Inc — 2.35%
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
FAQ
What is the difference between VHT and IYH?
Which is cheaper, VHT or IYH?
Should I own both VHT and IYH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.